 monoclon anti-t cell antibodi treatment graft-versus-host diseas sever combin immunodefici target antibodi activ complement cytotox cell surfac male child sever immunodefici unirradi blood transfus acut sever graft-versus-host diseas gvhd monoclon anti-t cell antibodi treatment gvhd confluent maculopapular rash liver function test skin biopsi separ peripher blood mononuclear cell rosett sheep red blood cell engraft cell nonrel hla type blood donor patient intraven monoclon dose mg/kg/day day vivo effect clinic improv skin rash return liver normal rang human complement compon fluoresc microscopi surfac engraft skin biopsi specimen biotin-avadin assay presenc cell studi vivo target monoclon antibodi cell gvhd activ complement cell